Metraipolis › archive › dc_e14672170ccc
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40970551
- DOI
- 10.1111/exd.70153
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:29:15.507Z
- SHA-256 of the archived text
b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10- Stable URL of this page
https://metraipolis.com/documento/dc_e14672170ccc
How to cite
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551 — Europe PMC (en), https://europepmc.org/article/MED/40970551 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e14672170ccc (Metraipolis archive dc_e14672170ccc, sha256 b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10)
BibTeX
@misc{dce14672170ccc,
title = {Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40970551},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e14672170ccc; sha256 b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40970551. Agents can read the archived copy with the MCP tool read_document.